Tackling the Allergy Crisis in Europe-Concerted Policy Action Needed
Allergy is one of the most common chronic diseases in Europe. Up to 20% of patients with allergies live with a severe
debilitating form of their condition, and struggle daily with the fear of a possible asthma attack, anaphylactic shock, or even death from an allergic reaction.
While at the beginning of the 20th century allergy was seen as a rare disease, in the last few decades we have witnessed a dramatic
increase in disease burden. Today, more than 150 million Europeans suffer from chronic allergic diseases and the current prediction is that by 2025 half of the entire EU population will be affected.
In light of these troubling statistics, the European Academy of Allergy and Clinical Immunology (EAACI) has a duty to alert EU policymakers to the growing public health burden posed by allergy in Europe and the need to implement policy actions to help health care practitioners address this problem.
The EAACI European Advocacy Manifesto proposes a series of evidence-based recommendations to tackle the burden of allergy in Europe, foster allergy research and help strengthen Allergology as a medical specialty.
Download the Advocacy Manifesto here.